Trending Now

Important medical research and remarkable case reports worth knowing.

Selected from high-relevance medical literature published in the last 14 days.

AllClinical ResearchCase Reports
FeaturedClinical ResearchAllergy & Immunology

Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.

Clin Pharmacol Drug DevSep 1, 2026Open access

This randomized controlled trial evaluated the pharmacokinetic and pharmacodynamic bio-similarity of ADL-018, a biosimilar to omalizumab, in 306 healthy adults.

Why it matters

The findings support the use of ADL-018 as a biosimilar to omalizumab, indicating it may provide similar efficacy and safety profiles, which is crucial for treatment decisions in allergy management.

Read summary

Also worth knowing

Clinical ResearchAllergy & Immunology

Asthma Exacerbation Risk and School Asthma Readiness.

This randomized controlled trial evaluated school asthma readiness and its association with asthma exacerbations in a cohort of 202 children aged 5 to 13 years, predominantly Black and non-Hispanic.

PediatricsSep 1, 2026Read summary
Clinical ResearchAllergy & Immunology

Effect of repeated exposure to an identical multi-user virtual reality anaphylaxis scenario on paramedic trainee performance: a randomized controlled trial.

This randomized controlled trial evaluated the impact of repeated exposure to a virtual reality (VR) anaphylaxis scenario on the performance of 125 paramedic trainees.

Sci RepSep 3, 2026Open accessRead summary
Case ReportAllergy & Immunology

Chronic autoimmune urticaria with worsening during the luteal phase suggestive of progesterone hypersensitivity successfully treated with rituximab.

A 30-year-old woman with glucocorticoid-dependent chronic spontaneous urticaria (CSU) presented with cyclical worsening of symptoms during her luteal phase.

Allergy Asthma ProcSep 1, 2026Read case
Case ReportMedical Genetics

A novel FLNA p.Pro2469Ser variant is associated with impaired T and NK cell function and immune dysregulation.

FLNA encodes filamin A, a ubiquitously expressed actin-binding cytoskeletal protein that cross-links actin filaments and links them to membrane-associated signaling complexes.

Immunol ResAug 31, 2026Open accessRead case
Clinical ResearchAllergy & Immunology

Epidemic Thunderstorm Asthma in China: A Systematic Review of an Artemisia-Associated Phenotype.

This systematic review examines epidemic thunderstorm asthma (ETSA) in China, focusing on its association with Artemisia pollen.

Clin Rev Allergy ImmunolSep 2, 2026Open accessRead summary
Case ReportAllergy & Immunology

Suspected menopause nutraceutical-induced eosinophilic ascites: a rare clinical presentation.

A middle-aged woman presented with a 2-month history of ascites and marked peripheral eosinophilia (49%). Analysis of her ascitic fluid revealed 90% eosinophils, with no malignancy detected.

BMJ Case RepSep 1, 2026Read case
Case ReportInfectious Diseases

Recurrent severe cutaneous reaction to fluoroquinolones and rifampicin in a human immunodeficiency virus-positive patient with disseminated tuberculosis: A rare case report.

A 47-year-old male with HIV and disseminated tuberculosis experienced recurrent maculopapular eruptions with mucosal involvement after exposure to multiple medications, including fluoroquinolones and rifampicin.

Indian J PharmacolSep 2, 2026Read case
Case ReportDermatology

Levocetirizine-induced paradoxical fixed drug eruption: A case report with causality assessment.

A patient developed a fixed drug eruption (FDE) after self-medicating with levocetirizine, presenting with hyperpigmented patches that progressed to blisters.

Indian J PharmacolSep 2, 2026Read case

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.